TechAviv
VC Fund
Tel Aviv, Israel
TechAviv is a VC fund in Tel Aviv focused on Software and Health Care. TechAviv is the global Israeli startup founders club and fund. We aim to harness our collective energy, knowledge and networks to help each other build better companies. Since 2007 our founders club members have helped each other build over 100 unicorns and public companies. Our founders fund, TechAviv Founder Partners, is backed and powered by 150of the world's most successful company builders. We've joined forces to actively support the next generation of iconic Israeli-founded companies at their earliest stages.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 27%
- Fund size:
- $26M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries TechAviv invests in
Stages TechAviv invests in
Countries TechAviv invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $3M–$53M
- Series A
- $14M–$47M
Investment Focus
Industry
- Software 3 (27%)
- Health Care 2 (18%)
- Biotechnology 2 (18%)
- Apps 1 (9%)
- FinTech 1 (9%)
Stage
- Seed 6 (55%)
- Series A 3 (27%)
- Pre-Seed 2 (18%)
Country
- Israel 3 (27%)
- United States 3 (27%)
- Egypt 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Yaron Samid
Founder and CEO
|
Founder and CEO | Total investments: 23 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Remepy is biotechnology research pioneering hybrid drugs. The company believes that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms ofAction™.It was founded in 2022 and is located in Ramat Gan, Tel Aviv. | $36M / Series A / Aug 12, 2026 | ||
| Dimer Health provides continuous care and support to the patients after hospital discharge. | $13.5M / Series A / Mar 23, 2026 | ||
| Rise is a credit-led platform that enables underserved consumers to access installment-based purchasing power. | Seed / Sep 23, 2025 | ||
| Leo™ is the world's first engineering design copilot, empowering engineers and designers to turn ideas into products in seconds. Leo's generative AI platform transforms text, sketches, specs, and CAD constraints into DFMA-optimized, full-assembly 3D CAD models, saving companies up to 70% of their engineering time and cost. Leading AIresearchers and mechanical engineers from MIT, Technion, Microsoft, and Elbit Systems founded Leo in 2023. | $5M / Seed / Sep 02, 2025 | ||
| Somite is a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies. | $47M / Series A / May 13, 2025 | ||
| Dimer Health provides continuous care and support to the patients after hospital discharge. | $3M / Seed / Sep 25, 2024 | ||
| Remepy is biotechnology research pioneering hybrid drugs. The company believes that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms ofAction™.It was founded in 2022 and is located in Ramat Gan, Tel Aviv. | $10M / Seed / May 01, 2024 | ||
| Somite is a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies. | $10.3M / Pre-Seed / Apr 10, 2024 | ||
| Descope enables any developer to create secure, frictionless authentication and user journeys for any application. It intends to make customer identity a business enabler. | $53M / Seed / Feb 15, 2023 | ||
| Leo™ is the world's first engineering design copilot, empowering engineers and designers to turn ideas into products in seconds. Leo's generative AI platform transforms text, sketches, specs, and CAD constraints into DFMA-optimized, full-assembly 3D CAD models, saving companies up to 70% of their engineering time and cost. Leading AIresearchers and mechanical engineers from MIT, Technion, Microsoft, and Elbit Systems founded Leo in 2023. | Pre-Seed / Jul 01, 2022 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does TechAviv invest in?
TechAviv invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is TechAviv's check size?
TechAviv typically joins rounds of $3M–$53M at Seed and $14M–$47M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds TechAviv participates in.
How do I contact TechAviv?
Public channels for TechAviv include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at TechAviv?
The team at TechAviv includes Yaron Samid (Founder and CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
